Epithra 50 mg Injection(Epirubicin)

Epithra 50 mg Injection(Epirubicin) 

Epithra 50 mg a product by Glenmark Pharmaceuticals Ltd. consist of epirubicin as a main ingredient. It is an anti-cancer medicine which used in the treatment of breast cancer. Epithra 50mg works by suppressing the action of an enzyme(topoisomerase II) which is involved in the DNA Multiplication of breast cancer cells. This also forms harmful chemical which damages the DNA and thus stops the further growth of breast cancer cells and eventually kills them.

Some common side effects suffered by the patients are rash, vomiting, conjunctivitis, nausea, mouth sore, hair loss. These side effects are usually seen in many of the patients who are consuming this injection.

Substitutes available

Zuvicin 50 mg Injection(by Zuventus Healthcare Ltd.)

Epicure 50 mg Injection(by Emcure Pharmaceuticals Ltd.)

Farmorubicin Rd 50 mg Injection(by Pfizer Ltd.)

Erubin 50 mg Injection(by RPG Life Science Ltd.)